8hon MSN
BioAtla outlines $800M peak sales target for Oz-V as FDA alignment paves way for phase III launch
Q3 2025 Management View Jay Short, Co-Founder, CEO & Chairman, emphasized that BioAtla is "currently in advanced stages to ...
8don MSN
Data scientists perform last rites for ‘dearly departed datasets’ in 2nd Trump administration
A group of U.S. data scientists has published a list of federal datasets that have been altered or removed since President ...
The next big advantage isn’t just AI — it’s smarter leadership. CXO 3.0 is where confidence, trust and intelligence drive ...
Globalstar, Inc. is rated a Strong Buy with a $69/share price target, citing future margin expansion and revenue growth. Read more on GSAT stock here.
X9, Inc. today announced positive results from its first-in-human clinical feasibility study evaluating the X9 Ultrasound ...
Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected acquisition ...
Putting the evidence together, it becomes clear that regulation and business models are late-stage refinements, not root ...
Monash University’s vice chancellor says she’s kept “awake at night” by how to make “campuses safe and respectful” after ...
Combine structured frameworks with a customizable assessment model to turn strategic fog into prioritized remediation plans ...
A new report finds B.C. charges industrial users a maximum of $2.25 per million litres of water — 70 times less than Quebec — ...
Although personality isn’t fixed. A Type A can soften into Type B after burnout, while a Type D may grow assertive through therapy or leadership roles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results